Aller au contenu
Activité et longévitéÉtude de cohorte4 min read

Short bursts of vigorous daily activity linked to lower cancer risk in non-exercisers

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults: The UK Biobank Accelerometry Study. · JAMA oncology · 2023 · Article original ↗

À retenir

Among 22 398 UK Biobank adults who did not exercise, a median 4.5 minutes per day of vigorous bursts lasting up to 1 minute was associated with a lower risk of total cancer (HR 0.80) and physical-activity-related cancer (HR 0.69) than none. This is an observational link in a mostly White sample, so it cannot prove the bursts themselves lower cancer risk.

Study design

Étude de cohorte

Reading basis

Published abstract

Reading focus

Association & confounding

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Vigorous activity is a time-efficient way to reach activity targets linked to cancer prevention, but structured exercise sessions are unappealing or out of reach for many people. The authors asked whether very short bursts of vigorous activity during daily life, called vigorous intermittent lifestyle physical activity (VILPA), were related to cancer incidence, and what minimal dose gave half of the maximum risk reduction.

Population et méthode

Prospective cohort of 22 398 self-reported nonexercising adults from the UK Biobank accelerometry subsample. Daily VILPA of up to 1 and up to 2 minutes was measured with wrist accelerometers worn on the dominant wrist. Participants were followed to October 30, 2021 for mortality and hospitalizations and June 30, 2021 for cancer registrations. Outcomes were total cancer and a composite of 13 cancer sites linked to low physical activity. Hazard ratios came from cubic spline models adjusted for age, sex, education, smoking, alcohol, sleep duration, fruit and vegetable intake, parental cancer history, and light, moderate and other vigorous activity.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Participants had a mean age of 62.0 years (SD 7.6); 10 122 (45.2%) were men and 21 509 (96.0%) were White. Over a mean 6.7 years (149 650 person-years) there were 2356 cancers, 1084 of them physical-activity-related; 92.3% of VILPA came in bouts of up to 1 minute.
  2. 2
    Daily VILPA time was related to cancer in a near-linear way, with steeper curves for physical-activity-related cancer than for total cancer.
  3. 3
    Compared with no VILPA, the median 4.5 minutes per day (bouts up to 1 minute) went with an HR of 0.80 (95% CI 0.69-0.92) for total cancer and 0.69 (95% CI 0.55-0.86) for physical-activity-related cancer.
  4. 4
    The minimal dose for half the maximum reduction was 3.4 minutes per day for total cancer (HR 0.83; 95% CI 0.73-0.93) and 3.7 minutes for physical-activity-related cancer (HR 0.72; 95% CI 0.59-0.88). Findings were similar for bouts of up to 2 minutes.

Limites et incertitude

  1. 1
    Observational design: people who naturally do more vigorous bursts may differ in health or other habits, and early undiagnosed illness could also reduce activity; the abstract does not describe how this was handled.
  2. 2
    Activity was measured by the accelerometer for a short window rather than across the 6.7 years of follow-up, so one measurement may not represent long-term habits.
  3. 3
    The sample was 96.0% White and drawn from a UK volunteer subsample, so results may not apply to other populations.
  4. 4
    The results are reported only for people who said they did not exercise, so they do not apply to those who already exercise.

Mise en perspective

Short vigorous efforts built into daily life, such as climbing stairs briskly or hurrying up a hill, were associated with lower cancer risk even among people who do not exercise, so doing a few minutes a day may be a realistic starting point. The data cannot show cause and effect or give a guaranteed risk reduction. Anyone with a medical condition should ask their clinician what intensity suits them.

Vos données

Wrist wearables can capture short bursts of vigorous movement through heart rate and active minutes, though consumer devices detect them less precisely than the research accelerometers used here. Compare your own weekly totals on the same device and wear position, and focus on whether the trend over weeks is rising.

Comprendre ce type de preuve

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Importance

Vigorous physical activity (VPA) is a time-efficient way to achieve recommended physical activity (PA) for cancer prevention, although structured longer bouts of VPA (via traditional exercise) are unappealing or inaccessible to many individuals.

Objectives

To evaluate the dose-response association of device-measured daily vigorous intermittent lifestyle physical activity (VILPA) with incident cancer, and to estimate the minimal dose required for a risk reduction of 50% of the maximum reduction.

Design, setting, and participants

This was a prospective cohort analysis of 22 398 self-reported nonexercising adults from the UK Biobank accelerometry subsample. Participants were followed up through October 30, 2021 (mortality and hospitalizations), or June 30, 2021 (cancer registrations).

Exposures

Daily VILPA of up to 1 and up to 2 minutes, assessed by accelerometers worn on participants' dominant wrist.

Main outcomes and measures

Incidence of total cancer and PA-related cancer (a composite outcome of 13 cancer sites associated with low PA levels). Hazard ratios and 95% CIs were estimated using cubic splines adjusted for age, sex, education level, smoking status, alcohol consumption, sleep duration, fruit and vegetable consumption, parental cancer history, light- and moderate-intensity PA, and VPA from bouts of more than 1 or 2 minute(s), as appropriate.

Results

The study sample comprised 22 398 participants (mean [SD] age, 62.0 [7.6] years; 10 122 [45.2%] men and 12 276 [54.8%] women; 21 509 [96.0%] White individuals). During a mean (SD) follow-up of 6.7 (1.2) years (149 650 person-years), 2356 total incident cancer events occurred, 1084 owing to PA-related cancer. Almost all (92.3%) of VILPA was accrued in bouts of up to 1 minute. Daily VILPA duration was associated with outcomes in a near-linear manner, with steeper dose-response curves for PA-related cancer than total cancer incidence. Compared with no VILPA, the median daily VILPA duration of bouts up to 1 minute (4.5 minutes per day) was associated with an HR of 0.80 (95% CI, 0.69-0.92) for total cancer and 0.69 (95% CI, 0.55-0.86) for PA-related cancer. The minimal dose was 3.4 minutes per day for total (HR, 0.83; 95% CI, 0.73-0.93) and 3.7 minutes for PA-related (HR, 0.72; 95% CI, 0.59-0.88) cancer incidence. Findings were similar for VILPA bout of up to 2 minutes.

Conclusions and relevance

The findings of this prospective cohort study indicate that small amounts of VILPA were associated with lower incident cancer risk. Daily VILPA may be a promising intervention for cancer prevention in populations not able or motivated to exercise in leisure time.

Sources et attribution

Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults: The UK Biobank Accelerometry Study.

Stamatakis E, Ahmadi MN, Friedenreich CM, Blodgett JM, Koster A, Holtermann A, Atkin A, Rangul V, Sherar LB, Teixeira-Pinto A, Ekelund U, Lee IM, Hamer M.

JAMA oncology · 2023-09-01

DOI: 10.1001/jamaoncol.2023.1830 ↗PubMed · 37498576 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse observationnelle

7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000

Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.

The Lancet Public Health

Explications approfondiesLire l’étude →
·Étude de cohorte

Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers

Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.

Nature Medicine

Explications approfondiesLire l’étude →
·Méta-analyse observationnelle

Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)

Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.

The Lancet Public Health

Explications approfondiesLire l’étude →
·Méta-analyse observationnelle

Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality

In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.

BMJ

Explications approfondiesLire l’étude →
Activité et longévité →